TCG Labs Soleil’s Juri Biosciences is offering EpimAb Biotherapeutics up to $210 million biobucks for exclusive licensing ...

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...

Phase 3-Ready Design Insights: Planning is ongoing for a Phase 3 design similar to the design of ILYX-002-201 de-risking the ...

For the first time, Quadria has raised around 10% of the fund from Indian investors, including family offices, insurance ...

Trans-Tasman drug developer Aft Pharmaceuticals is targeting lucrative niche diseases its Big Pharma rivals have ignored ...

BioCryst has also filed its line extension application for the use of ORLADEYO oral granules in patients with HAE aged 2 to 11 years with the European Medicines Agency. Additional regulatory filings ...

At SNEC, the pilot took place from January to June 2024. Enigma was used to conduct clinical audits for cataract surgeries. Clinical audits are mandatory processes to check if healthcare was delivered ...

Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness ...

Akums Drugs and Pharma has announced the resignation of Amrut Medhekar, CEO- CDMO Business of the Company effective July 15 ...

Ocugen (NASDAQ:OCGN) disclosed on Tuesday that its gene therapy candidate, OCU410ST, has been granted rare pediatric disease status by the U.S. FDA. The designation covers the treatment of ...

The policy, which creates a bifurcated system for testing vaccines in supposedly low- and high-risk populations, serves ...